Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial.
Alavi Darazam I, Shokouhi S, Mardani M, Pourhoseingholi MA, Rabiei MM, Hatami F, Shabani M, Moradi O, Gharehbagh FJ, Irvani SSN, Amirdosara M, Hajiesmaeili M, Rezaei O, Khoshkar A, Lotfollahi L, Gachkar L, Dehbsneh HS, Khalili N, Soleymaninia A, Kusha AH, Shoushtari MT, Torabinavid P.
Alavi Darazam I, et al. Among authors: hatami f.
Int Immunopharmacol. 2021 Oct;99:107969. doi: 10.1016/j.intimp.2021.107969. Epub 2021 Jul 10.
Int Immunopharmacol. 2021.
PMID: 34273635
Free PMC article.
Review.